Martee L. Hensley

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses”.

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses

Nature Medicine(2024)10.1038/s41591-024-02942-7

N/A

0.790DataRank · unranked

26 citations

Beryl Manning‐Geist, Qin Zhou, Tara E. Soumerai, Aliya Holland, Arnaud Da Cruz Paula +23 more

The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.10.020

N/A

0DataRank · unranked

22 citations

Martee L. Hensley, Melody So, Qin Zhou, Alexia Iasonos, Mario M. Leitão +6 more

A Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal CA-125 Screening among Women at Increased Genetic Risk of Ovarian Cancer: Design and Baseline Characteristics: A Gynecologic Oncology Group Study

UNC Libraries(2020)10.17615/pk34-dj40

N/A

0DataRank · unranked

0 citations

Jack Basil, Mark H. Greene, Martee L. Hensley, John F. Boggess, Lori M. Minasian +11 more

Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100852

N/A

0DataRank · unranked

36 citations

Claire F. Friedman, Jennifer J. Mueller, Ryma Benayed, Marc Ladanyi, Maria E. Arcila +4 more

Evaluating the role of aromatase inhibitors (AIs) in the treatment of endometrial stromal sarcomas (ESS).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5575

N/A

0DataRank · unranked

1 citations

Karen A. Cadoo, Sarah Chiang, Jennifer J. Mueller, Martee L. Hensley, Roisin E. O’Cearbhaill +1 more

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

Nature Communications(2022)10.1038/s41467-022-30453-x

N/A

0DataRank · unranked

215 citations

Francisco Sánchez-Vega, Shaleigh Smith, Cristina R. Antonescu, Evan Rosenbaum, Hongyu Shi +42 more

Primary characteristics and outcomes of newly diagnosed low-grade endometrial stromal sarcoma

International Journal of Gynecological Cancer(2022)10.1136/ijgc-2022-003383

N/A

0DataRank · unranked

11 citations

Corinne Jansen, Kathryn Miller, Sarah Chiang, Kaled M. Alektiar, Martee L. Hensley +4 more

Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.100980

N/A

0DataRank · unranked

4 citations

Karen A. Cadoo, Sarah Chiang, Diana Mandelker, Raazi Bajwa, Alexia Iasonos +5 more

Germline drivers of gynecologic carcinosarcomas

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.04.024

N/A

0DataRank · unranked

8 citations

Sushmita Gordhandas, Ozge Ceyhan‐Birsoy, Yelena Kemel, Anna Maio, Erin Salo‐Mullen +22 more

Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator’s choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior chemotherapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps11584

N/A

0DataRank · unranked

2 citations

Sumithra J. Mandrekar, Jacob B. Allred, Stephanie Berg, Martee L. Hensley, Brian Andrew Van Tine +4 more

3D genomics identify alternate mechanisms of homologous recombination deficiency in uterine sarcoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e17624

N/A

0DataRank · unranked

0 citations

Martee L. Hensley, Varshini Vasudevaraja, Ivy Tran, Yiying Yang, Colin J.R. Stewart +6 more

Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2519

N/A

0DataRank · unranked

20 citations

Kenneth Seier, Viswatej Avutu, Lauren B. Banks, Jason E. Chan, Ping Chi +20 more

Expanding the Spectrum of NR4A3 Fusion–Positive Gynecologic Leiomyosarcomas

Modern Pathology(2024)10.1016/j.modpat.2024.100474

N/A

0DataRank · unranked

17 citations

Kerry Mullaney, Sara DiNapoli, Mario M. Leitão, Martee L. Hensley, Nora Katabi +5 more

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.023

N/A

0DataRank · unranked

2 citations

Matthew Flint, M. Herman Chui, Jason Konner, Claire F. Friedman, Angela K. Green +14 more

Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3959

N/A

0DataRank · unranked

119 citations

Shweta S. Chavan, David B. Solit, Rajmohan Murali, Robert A. Soslow, Sarah Chiang +9 more

Uterine leiomyosarcoma progression: A study of serial recurrences

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.09.007

N/A

0DataRank · unranked

0 citations

David N. Brown, Kathryn Miller, Christina Curtin, Pier Selenica, Arnaud Da Cruz Paula +7 more